Innovus Pharma (INNV) Earnings
|
Expand Research on INNV
| Next EPS Date | 5/7/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -80.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.6% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/24 | Q324 | N/A | -$0.03 | N/A | N/A | $188.25M | N/A | N/A | N/A | ||
| 2/6/24 | Q224 | -$0.03 | -$0.03 | $0.00 | $188.89M | $184.01M | N/A |  | | Details | |
| 11/7/23 | Q124 | -$0.08 | -$0.04 | -$0.04 | $182.5M | $177.95M | N/A | | | Details | |
9/12/23  |
Q423 | N/A | -$0.04 | N/A | $176.87M | $175.71M | N/A | N/A | N/A | ||
| 5/9/23 |
Q323 | N/A | -$0.05 | N/A | N/A | $174.14M | N/A | N/A | N/A | ||
| 2/7/23 | Q223 | -$0.07 | -$0.08 | +$0.01 | $167.46M | $169.86M | N/A | | | Details | |
| 11/8/22 | Q123 | -$0.10 | -$0.03 | -$0.07 | $171.22M | $172.15M | N/A | | | Details | |
| 9/13/22 | Q222 | $0.05 | -$0.01 | +$0.06 | $171.62M | $173.74M | N/A | | | Details |
